Market openNon-fractional
Artivion/AORT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Artivion
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
Ticker
AORT
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Kennesaw, United States
Employees
1,500
Website
artivion.com
Artivion Metrics
BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$0.23
EPS
1.66
Beta
-
Dividend rate
Price and volume
Market cap
$1.1B
Beta
1.66
Financial strength
Current ratio
6.039
Quick ratio
2.786
Long term debt to equity
121.746
Total debt to equity
122.927
Interest coverage (TTM)
0.81%
Management effectiveness
Return on assets (TTM)
3.59%
Return on equity (TTM)
-3.35%
Valuation
Price to revenue (TTM)
2.875
Price to book
3.63
Price to tangible book (TTM)
-9.08
Price to free cash flow (TTM)
168.378
Growth
Revenue change (TTM)
15.13%
Earnings per share change (TTM)
-68.26%
3-year revenue growth
12.60%
3-year earnings per share growth
-12.14%
What the Analysts think about Artivion
Analyst Ratings
Majority rating from 5 analysts.
Artivion Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$97M
4.06%
Net income
$7.5M
-292.31%
Profit margin
7.70%
-285.10%
Artivion Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.08
-$0.24
-$0.10
$0.18
-
Expected
-$0.08
-$0.06
-$0.11
-$0.09
-$0.06
Surprise
5.26%
313.79%
-4.76%
-310.77%
-
Artivion News
AllArticlesVideos
Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Artivion Reports First Quarter 2024 Financial Results
PRNewsWire·2 months ago
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
PRNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Artivion stock?
Artivion (AORT) has a market cap of $1.1B as of July 05, 2024.
What is the P/E ratio for Artivion stock?
The price to earnings (P/E) ratio for Artivion (AORT) stock is 0 as of July 05, 2024.
Does Artivion stock pay dividends?
No, Artivion (AORT) stock does not pay dividends to its shareholders as of July 05, 2024.
When is the next Artivion dividend payment date?
Artivion (AORT) stock does not pay dividends to its shareholders.
What is the beta indicator for Artivion?
Artivion (AORT) has a beta rating of 1.66. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Artivion stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.